Saccharomyces cerevisiae, commonly known as baker's yeast, is a well-studied eukaryotic organism with significant applications in basic research and industry . Its extensive use in research and food production has established a long history of safe use . S. cerevisiae serves as a valuable model organism for eukaryotic studies . Although generally non-pathogenic, it can act as an opportunistic pathogen in individuals with compromised immunity .
YDR193W is a putative uncharacterized protein in S. cerevisiae. The term "putative" suggests that the protein's existence is predicted based on genomic data, but its function has not been experimentally determined.
The Anaphase-Promoting Complex/Cyclosome (APC/C) is a large multi-subunit complex involved in cell cycle regulation. Studies of S. cerevisiae APC/C have provided insights into its structure and mechanism . The APC/C in S. cerevisiae shares conserved structural elements and functional mechanisms with its human counterpart, but also exhibits specific variations .
Key findings regarding the S. cerevisiae APC/C include:
Several studies provide detailed insights into the interactions and functions of APC/C subunits in S. cerevisiae:
APC9: Required for the efficient incorporation of CDC27/APC3 into the assembled APC/C .
SWM1/APC13 and CDC26/APC12: Required for the stoichiometric assembly of APC3, APC6, and APC9 into the complex .
MND2: The S. cerevisiae ortholog of human APC15, sharing related functions in promoting the auto-ubiquitylation of CDC20 .
APC13: Engages structurally equivalent sites on APC8B, APC6A, APC6B, and APC3A, similar to human APC13 .
APC9: Contains segments that interact with APC3A and APC6A, explaining why APC9 deletion causes loss of both APC3 and APC9 from purified APC/C complexes .
STRING: 4932.YDR193W
YDR193W is a putative uncharacterized protein in the model organism Saccharomyces cerevisiae (budding yeast). Its significance stems from being part of the approximately 6-13% of proteins in the human proteome that have been detected but remain functionally uncharacterized . S. cerevisiae serves as an excellent model organism for studying such proteins due to its well-characterized genome, ease of genetic manipulation, and the high conservation of many fundamental biological processes between yeast and humans . The characterization of YDR193W could potentially reveal new insights into conserved cellular functions and contribute to our understanding of similar uncharacterized proteins in higher organisms, including humans.
For recombinant YDR193W production, Escherichia coli is the most commonly used expression system due to its rapid growth, high protein yields, and established protocols . Specifically, available data shows that recombinant full-length YDR193W has been successfully expressed in E. coli with an N-terminal His-tag . When designing an expression system for YDR193W, researchers should consider:
Strain selection: BL21(DE3) serves as a workhorse strain for non-toxic proteins, while BL21(DE3) pLysS or pLysE can repress basal expression levels for toxic proteins
Promoter choice: Options include T7 promoter (high expression but strict regulation needed), trc and tac promoters (moderate expression), or BAD promoter (tightly regulated)
Vector considerations: Plasmid copy number affects expression levels; high-copy pMB1' origin or low-copy p15A origin should be selected based on protein toxicity and desired yield
Codon optimization: May increase expression up to 13-fold compared to non-optimized sequences
Multiple complementary methods can be employed to verify the expression of YDR193W:
SDS-PAGE: The most basic method for confirming protein expression and approximate molecular weight. For YDR193W, which has a molecular weight of approximately 14-15 kDa plus any tag size, standard 12-15% gels are recommended .
Western blotting: More specific detection using antibodies against the His-tag or against YDR193W directly if antibodies are available.
Mass spectrometry: For precise identification and confirmation of the protein sequence:
Fluorescence detection: If expressed as a fusion with a fluorescent reporter such as YFP, expression can be monitored in real-time .
According to the Saccharomyces Genome Database (SGD), no expression data is currently available for YDR193W . This lack of expression data suggests that YDR193W may be:
Expressed at very low levels under standard laboratory conditions
Expressed only under specific environmental conditions not commonly tested
Expressed only during specific developmental or stress responses
Potentially a misannotated open reading frame
Researchers interested in studying YDR193W expression in its native context should consider genome-wide techniques such as RNA-seq under various growth conditions or stress responses, or targeted approaches such as adding epitope tags to the endogenous locus to facilitate detection of the native protein. The SPELL (Serial Pattern of Expression Levels Locator) tool referenced in the SGD might help identify conditions under which similar genes are expressed, potentially guiding experimental design .
Functional characterization of uncharacterized proteins like YDR193W requires a multi-faceted experimental approach following these methodological steps:
Independent variables: Potential conditions affecting YDR193W function (e.g., nutrient availability, stress conditions, genetic background)
Dependent variables: Measurable outputs (e.g., growth rate, biochemical activity, interaction profiles)
Control for extraneous variables: Use isogenic strains differing only in YDR193W expression
Step 2: Design systematic experimental treatments
For YDR193W characterization, implement a matrix of approaches:
Comparative genomics analysis:
Gene deletion and overexpression studies:
Protein localization studies:
Generate GFP/RFP fusions to determine subcellular localization
Perform fractionation studies coupled with Western blot analysis
Interactome mapping:
High-throughput phenotypic screening:
Test growth under hundreds of environmental conditions and chemical stressors
Analyze metabolomic changes in deletion/overexpression strains
When analyzing results, ensure proper statistical analysis and validation through complementary methods to avoid artifacts from any single approach.
For efficient purification of recombinant YDR193W, a systematic approach should be followed based on its physicochemical properties:
Expression optimization:
Solubility assessment and enhancement:
Perform small-scale expression tests with varied conditions (16-37°C induction)
If inclusion bodies form, test solubilization strategies:
Co-expression with chaperones (GroEL/ES, DnaK)
Fusion tags (MBP, SUMO, Trx) beyond the His-tag
Lower expression temperature (16°C) and IPTG concentration
Purification protocol:
Primary capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA
Secondary purification: Size exclusion chromatography to remove aggregates
Buffer optimization: Screen multiple buffers varying pH (6.5-8.5), salt (50-500mM NaCl), and additives (glycerol, reducing agents)
Quality control:
Storage optimization:
Computational prediction of YDR193W function should follow a multi-layered approach:
Sequence-based analysis:
Homology detection: Search for remote homologs using PSI-BLAST, HHpred, or HMMER
Domain and motif identification: Scan InterPro, PFAM, PROSITE databases
Disorder prediction: Use PONDR, IUPred to identify structurally disordered regions
Secondary structure prediction: Apply PSIPRED, JPred for structural elements
Structural prediction:
Generate 3D structural models using AlphaFold2 or RoseTTAFold
Perform structural similarity searches against PDB using DALI or TM-align
Identify potential binding pockets using CASTp or SiteMap
Systems biology integration:
Functional prediction:
Employ Gene Ontology term prediction tools (PANNZER, DeepGOPlus)
Use pathway mapping tools to predict metabolic or signaling roles
Apply clustering algorithms to group with functionally characterized proteins
Validation planning:
Design experiments to test top computational predictions
Prioritize predictions with highest confidence scores
Focus on predictions supported by multiple methods
This systematic approach has successfully reduced the number of uncharacterized proteins (uPE1) in the human proteome from 13% to 6% in recent years , demonstrating its effectiveness when applied rigorously.
To comprehensively identify and validate interaction partners of YDR193W, employ a combination of complementary techniques:
Affinity purification-mass spectrometry (AP-MS):
Express tagged YDR193W (His-tag or TAP-tag) in yeast
Perform gentle lysis preserving protein complexes
Capture complexes via affinity purification
Identify components by mass spectrometry
Use SILAC or TMT labeling for quantitative assessment
Compare results with control purifications to filter non-specific interactions
Yeast two-hybrid screening:
Create both DNA-binding domain and activation domain fusions
Screen against yeast genomic or cDNA libraries
Verify positive interactions through reverse Y2H and co-immunoprecipitation
Use N- and C-terminal fusions to minimize false negatives
Proximity-based labeling:
Fuse YDR193W to BioID or APEX2 enzymes
Express fusion protein in yeast cells
Allow proximity-dependent labeling to occur
Purify biotinylated proteins and identify by MS
This approach captures transient and weak interactions
Genetic interaction mapping:
Create YDR193W deletion strain
Perform synthetic genetic array (SGA) analysis
Identify genes with synthetic lethal/sick phenotypes
These often represent parallel pathways or complex members
Advanced techniques:
Data integration should follow using Cytoscape or similar platforms to construct interaction networks and identify key functional clusters.
Expression of uncharacterized proteins like YDR193W in heterologous systems presents several challenges that can be systematically addressed:
Challenge: Low expression levels
Solution approaches:
Codon optimization: Design sequence adapted to host codon usage, which can increase yield up to 13-fold
Promoter selection: Test multiple promoters in parallel (P T7, Plac trc, P tac, P BAD) to identify optimal expression control
Vector backbone modification: Compare high-copy (pMB1') vs. low-copy (p15A) origins of replication
Host strain engineering: Test expression in an E. coli BL21 ΔackA strain, which shows higher recombinant protein production due to reduced acetate production
Challenge: Inclusion body formation
Solution approaches:
Challenge: Protein toxicity to host
Solution approaches:
Tight expression control: Use pLysS/pLysE systems to reduce basal expression
Induction optimization: Titrate inducer concentration for minimal toxicity
Specialized growth media: Test autoinduction media for gradual protein expression
Metabolic burden reduction: Balance plasmid copy number and promoter strength
Challenge: Improper folding
Solution approaches:
Expression in yeast: Return to native host or use Pichia pastoris
Periplasmic expression: Direct protein to E. coli periplasm using signal sequences
Cell-free protein synthesis: Bypass cellular toxicity entirely
Challenge: Post-translational modifications
Solution approaches:
Eukaryotic expression systems: Switch to insect or mammalian cells if modifications are crucial
Co-expression of modifying enzymes: Introduce necessary kinases, glycosyltransferases
A systematic experimental design testing multiple conditions in parallel is recommended to efficiently identify optimal expression parameters.
A comprehensive structural characterization of YDR193W requires a multi-technique approach:
Computational structure prediction and analysis:
Generate models using AlphaFold2 and RoseTTAFold
Analyze predicted structure for functional clues:
Identify potential binding pockets
Search for structural homologs
Predict potential membrane-spanning regions
Use these predictions to guide experimental approaches
X-ray crystallography workflow:
Protein engineering: Design constructs removing flexible regions identified computationally
Crystallization screening: Test thousands of conditions using nanoliter-scale robotics
Optimization: Refine promising conditions by varying pH, precipitant, additives
Data collection: Collect diffraction data at synchrotron facilities
Structure determination: Use molecular replacement or experimental phasing methods
NMR spectroscopy approach:
Isotopic labeling: Express protein with 15N, 13C enrichment
Sample optimization: Screen buffers for optimal peak dispersion
Spectral acquisition: Collect 2D and 3D NMR spectra
Structure calculation: Assign resonances and derive distance constraints
Particularly suitable if YDR193W is under 20 kDa in size
Cryo-electron microscopy:
More suitable if YDR193W forms larger complexes
Sample preparation: Optimize grid freezing conditions
Data collection: Acquire thousands of particle images
Processing: Perform 2D classification and 3D reconstruction
Hybrid methods:
Small-angle X-ray scattering (SAXS): For solution structure
HDX-MS: To probe dynamics and ligand interactions
Integrative modeling: Combine data from multiple techniques
Before investing in high-resolution techniques, preliminary characterization using circular dichroism and thermal shift assays is recommended to confirm proper folding and stability of the purified protein.
To systematically investigate YDR193W's role in cellular pathways, implement a multi-tiered experimental design:
Phenotypic profiling under varied conditions:
Create precision deletion strains (ΔYDR193W) and tagged/overexpression variants
Subject strains to comprehensive phenotypic array testing:
Growth in different carbon sources and nitrogen sources
Response to various stressors (oxidative, heat, osmotic)
Sensitivity to drugs with known mechanisms of action
Analyze growth kinetics using automated plate readers for quantitative assessment
Design as a full factorial experiment to identify condition-specific functions
Transcriptomic and proteomic analysis:
Perform RNA-seq comparing ΔYDR193W to wild-type under standard and stress conditions
Apply SILAC or TMT proteomics to identify affected proteins
Analyze data using pathway enrichment tools to identify perturbed processes
Validate key findings with RT-qPCR and Western blotting
Metabolomic investigation:
Measure metabolite changes in ΔYDR193W vs. wild-type using LC-MS/MS
Focus on central carbon metabolism, lipid metabolism, and amino acid pathways
Integrate with transcriptomic/proteomic data for pathway mapping
Genetic interaction mapping:
Perform synthetic genetic array (SGA) analysis or CRISPR-based screens
Create double mutants with genes in major cellular pathways
Identify synthetic lethal, suppressive, or epistatic relationships
Map YDR193W to specific pathways based on interaction profiles
Localization and dynamics studies:
Track YDR193W-GFP localization during cell cycle and stress responses
Perform time-lapse microscopy to detect dynamic relocalization
Co-localize with markers of cellular compartments
This systematic approach allows for unbiased hypothesis generation followed by focused validation experiments, leveraging the power of S. cerevisiae as a model organism where "processes that one can study with relative ease in yeast are identical in most respects to the ways in which human cells repair DNA damage and generate genetic diversity" .
To identify and confirm functional conservation of YDR193W orthologs across species, implement this methodological framework:
Computational identification of putative orthologs:
Create clusters of orthologs (ScCOGs) and homologs (ScCHGs) across species
Employ reciprocal BLAST, OrthoMCL, and HMMer for sensitive detection
Generate phylogenetic trees to distinguish orthologs from paralogs
Calculate sequence conservation metrics and identify conserved motifs
Apply this process across 700+ organisms as done in previous studies
Functional complementation testing:
Clone identified orthologs from other species (starting with closely related fungi)
Express these orthologs in ΔYDR193W S. cerevisiae strain
Test for phenotypic rescue under conditions where YDR193W deletion shows defects
Design appropriate controls:
Empty vector
Wild-type YDR193W (positive control)
Unrelated protein (negative control)
Domain swapping experiments:
Create chimeric proteins with domains from different species' orthologs
Express in ΔYDR193W strain and assess functionality
Map functionally conserved regions through systematic domain analysis
Comparative phenotypic analysis:
Create knockout/knockdown of orthologs in model organisms:
S. pombe (fission yeast)
C. elegans (nematode)
D. melanogaster (fruit fly)
Human cell lines (if ortholog identified)
Compare phenotypes across species for functional conservation patterns
Biochemical characterization across species:
Express and purify recombinant proteins from multiple species
Compare biochemical properties (substrate specificity, binding partners)
Perform structural studies to identify conserved structural elements
This approach has been validated in previous studies where "S. cerevisiae is predicted to be a good model in which to study a significant fraction of common biological processes" across species . The methods enable researchers to determine both the extent of conservation and the evolutionary trajectory of the protein function.